ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

The world’s largest brain research prize is Danish! And we will soon be announcing this year’s winners
2. February 2018
Scientists have found the first Native American
4. January 2018
The Lundbeck Foundation is ready to award historically large grants to brain research
12. December 2017